| __timestamp | Intra-Cellular Therapies, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10337679 | 6795238 |
| Thursday, January 1, 2015 | 18187286 | 7454247 |
| Friday, January 1, 2016 | 24758063 | 10345862 |
| Sunday, January 1, 2017 | 23666957 | 16984203 |
| Monday, January 1, 2018 | 30099855 | 16187290 |
| Tuesday, January 1, 2019 | 64947625 | 9299233.54 |
| Wednesday, January 1, 2020 | 186363444 | 19232000 |
| Friday, January 1, 2021 | 272611040 | 23611000 |
| Saturday, January 1, 2022 | 358782000 | 26700000 |
| Sunday, January 1, 2023 | 409864000 | 28215000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Intra-Cellular Therapies, Inc. and Summit Therapeutics Inc. over the past decade.
From 2014 to 2023, Intra-Cellular Therapies, Inc. has seen a staggering increase in SG&A expenses, growing nearly 40 times from 2014 to 2023. This reflects the company's aggressive expansion and investment in its operational infrastructure.
In contrast, Summit Therapeutics Inc. has maintained a more conservative growth in SG&A expenses, with a modest increase of approximately 4 times over the same period. This suggests a more cautious approach to scaling operations.
These trends highlight the diverse strategies employed by biotech firms in managing their growth and operational costs.
Cost Management Insights: SG&A Expenses for Zoetis Inc. and Intra-Cellular Therapies, Inc.
Cost Management Insights: SG&A Expenses for Intra-Cellular Therapies, Inc. and Alkermes plc
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Insmed Incorporated
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Jazz Pharmaceuticals plc
Summit Therapeutics Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs TG Therapeutics, Inc.
Summit Therapeutics Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Apellis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Travere Therapeutics, Inc.